This is due to the inhibition of DNA synthesis (specifically purines and thymidine)
In some embodiments, the otic formulation or composition contains at least one viscosity modulating agent that provides the otic formulation or composition with a viscosity of at least about 10 cP, about 20 cP, about 30 cP, about 40 cP, about 50 cP, about 60 cP, about 70 cP, about 80 cP, about 90 cP, about 100 cP, about 200 cP, about 300 cP, about 400 cP, about 500 cP, about 600 cP, about 700 cP, about 800 cP, about 900 cP, about 1000 cP, about 2,000 cP, about 3,000 cP, about 4,000 cP, about 5,000 cP, about 6,000 cP, about 7,000 cP, about 8,000 cP, about 9,000 cP, about 10,000 cP, about 15,000 cP, or about 20,000 cP
Research applications include receptor pharmacology, ligand-binding dynamics, signal transduction characterization, structure-activity relationship investigations, and comparative studies of GHS-R1a agonist activity
Munib personally reviews your medical history, current health status, and treatment goals before recommending B12 therapy
Unless things have changed very recently, it is not against the law to repackage some products that have not been sold to represent them with later sell by dates either
